Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.278
-0.002 (-0.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.284
+0.006 (2.01%)
After-hours: Apr 28, 2026, 4:31 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $43.91 million as of April 28, 2026. Its market cap has decreased by -84.91% in one year.
Market Cap
43.91M
Enterprise Value
3.93M
1-Year Change
-84.91%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $43.91M, a decrease of -64.82%. That is a compound annual growth rate of -13.84%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 49.08M |
| Nutriband | 48.57M |
| Telomir Pharmaceuticals | 48.13M |
| Xilio Therapeutics | 48.05M |
| Hyperion DeFi | 47.50M |
| Rein Therapeutics | 46.54M |
| Dogwood Therapeutics | 46.09M |
| Rallybio | 45.65M |